Aurobindo Pharma Market Cap

Aurobindo Pharma has a market cap or net worth of 651.08 billion as of June 27, 2025. Its market cap has decreased by -12.17% in one year.

Market Cap

651.08B

Enterprise Value

651.29B

Revenue

317.24B

Ranking

n/a

PE Ratio

18.74

Stock Price

1,125.00

Market Cap Chart

Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 651.08B, an increase of 6,679.76%. That is a compound annual growth rate of 20.12%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	652.36B	-15.83%
Dec 31, 2024	775.08B	22.03%
Dec 29, 2023	635.16B	147.32%
Dec 30, 2022	256.82B	-40.31%
Dec 31, 2021	430.28B	-20.29%
Dec 31, 2020	539.83B	101.66%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	3,986.97B
Divi's Laboratories	1,742.93B
Cipla	1,213.50B
Apollo Hospitals Enterprise	1,007.36B
Zydus Lifesciences	970.56B
Mankind Pharma	952.37B
Fortis Healthcare	577.84B
Alkem Laboratories	575.23B

Market Cap Rankings